Maker Gives Up on Alzheimer's Drug
Biogen announced Wednesday that it is stopping its clinical trials of an Alzheimer's drug, will no longer sell it, and is forsaking the ownership rights. Along with federal...
Source: newser.com
📰 More Aduhelm News
More Aduhelm News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from More Aduhelm. Real-time updates on events, politics, business and more.